Home › Metastatic Cancer › Florida › Sarasota
Metastatic Cancer clinical trials in Sarasota, FL
19 studies for Metastatic Cancer are looking for participants at sites in and around Sarasota (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
RecruitingPhase 3
- Florida Cancer Specialists - South, Sarasota
A Study of ASP3082 in Adults With Advanced Solid Tumors
RecruitingPhase 1
- Florida Cancer Specialists & Research Institute Sarasota, Sarasota
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- Florida Cancer Specialists, Sarasota
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Florida Cancer Specialists, Sarasota
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Florida Cancer Specialists, Sarasota
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- Florida Cancer Specialists, Sarasota
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RecruitingPhase 1/2
- Florida Cancer Specialists & Research Institute - Sarasota, Sarasota
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Clinical Study Site, Sarasota
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
RecruitingPhase 1
- Florida Cancer Specialist, Sarasota
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RecruitingPhase 1/2
- Avenzo Therapeutics Recruiting Site, Sarasota
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Florida Cancer Specialists, Sarasota
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- Florida Cancer Specalists, Sarasota
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
RecruitingPhase 1
- SCRI Florida Cancer Specialists - Sarasota, Sarasota
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Florida Cancer Specialists, Sarasota
A Study of PYX-201 in Advanced Solid Tumors
RecruitingPhase 1
- SCRI - Florida Cancer Specialists, Sarasota
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RecruitingPhase 1
- Florida Cancer Specialists, Sarasota
A Study of LY4175408 in Participants With Advanced Cancer
RecruitingPhase 1
- Florida Cancer Specialists - Sarasota, Sarasota
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RecruitingPhase 1
- Florida Cancer Specialists, Sarasota
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- Florida Cancer Specialists, Sarasota
Metastatic Cancer trials in other cities
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Other studies in Sarasota
- Non-Small Cell Lung Cancer17 studies
- Colorectal Cancer16 studies
- Ovarian Cancer16 studies
- Endometrial Cancer14 studies
- Breast Cancer12 studies
- Cancer (all types)11 studies
- Triple-Negative Breast Cancer8 studies
- Lung Cancer7 studies
- Pancreatic Cancer7 studies
- Atrial Fibrillation7 studies
- Prostate Cancer6 studies
- Steatotic Liver Disease6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.